THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE DELIVERY DATE OF CLIN 1001 FROM 25 SEPTEMBER 2025 TO 30 N…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- W911SR24F0016
- Contractor
- EMERGENT BIODEFENSE OPERATIONS LANSING LLC
- Awarding agency
- Department of Defense
- Sub-agency / office
- Department of the Army
- Award amount
- $41,801,810
- Period of performance
- Jan 22, 2024 – Nov 30, 2025
- NAICS
- 325411 — Medicinal and Botanical Manufacturing
- PSC
- PSC 6505
- Place of performance
- LANSING, MI, 489062933, USA
- Competition
- NOT AVAILABLE FOR COMPETITION
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $41,801,810 · Obligated $41,801,810 · Potential value $41,801,810 · Latest action obligation $0
- Parent award
- W911SR24D0001
Public award description
THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE DELIVERY DATE OF CLIN 1001 FROM 25 SEPTEMBER 2025 TO 30 NOVEMBER 2025.
Related intelligence
Related Federal Awards
- · SPE2D826F35FX — 4572123426!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · AMERISOURCEBERGEN DRUG CORP · Department of Defense · $76,853
- · SPE2D826FAP1H — 4572125002!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · AMERISOURCEBERGEN DRUG CORP · Department of Defense · $61,854
- · SPE2D826F35FT — 4572124492!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · AMERISOURCEBERGEN DRUG CORP · Department of Defense · $61,380
- · SPE2D826F35GH — 4572123830!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · AMERISOURCEBERGEN DRUG CORP · Department of Defense · $50,053
- · SPE2D826F35GQ — 4572124468!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · AMERISOURCEBERGEN DRUG CORP · Department of Defense · $29,910
- · SPE2D826F35HB — 4572123468!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · AMERISOURCEBERGEN DRUG CORP · Department of Defense · $26,646